Discover how advanced microphysiological systems are transforming drug discovery, development, translational research, and regulatory compliance in our Organoids to Organ on a chip comparison white paper.

Why read the white paper?

Are you leveraging organoids but running into their limitations? This white paper explores how organ-on-a-chip (OOC) platforms take physiological relevance, assay sensitivity, and translational power to the next level. Learn how integrating perfusion, immune components, and multi-organ models can help you generate deeper insights, bridge preclinical and clinical gaps, and support global regulatory momentum towards animal-free drug development.

Key Takeaways

• Understand the intrinsic limitations of organoids and how to overcome them with upgraded workflows
• Discover how to unlock greater assay sensitivity, repeat drug exposure studies, more physiologically relevant barrier organ research, and immune-mediated event analysis
• See how OOC models enable deeper insights and biomarker detection
• Get evidence-based recommendations for integrating advanced in vitro models into your R&D workflows
• Support your move toward animal-free, regulatory-compliant drug development

Table of Contents

1. Executive Summary
2. Introduction
3. Limitations of traditional organoid models
4. The advances of microphysiological systems
5. What do next generation organoids look like?
6. Conclusions and recommendations
7. References

Download the white paper now to future-proof your research and stay ahead in the evolving landscape of in vitro modeling.